Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Tofacitinib Citrate in Dermatitis, Atopic: CTRI/2026/04/109774 Clinical Landscape Report 2026
18 September 2026
CTRI/2026/04/109774 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apremilast in Psoriasis vulgaris: CTRI/2026/04/109640 Clinical Landscape Report 2026
18 September 2026
CTRI/2026/04/109640 clinical landscape for Psoriasis vulgaris: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
IBI-3033 in Dermatitis, Atopic: NCT07549984 Clinical Landscape Report 2026
18 September 2026
NCT07549984 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SYX-5219 in Severe Atopic Dermatitis: NCT07558668 Clinical Landscape Report 2026
18 September 2026
NCT07558668 clinical landscape for Severe Atopic Dermatitis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Roflumilast in Pruritus: NCT07560618 Clinical Landscape Report 2026
18 September 2026
NCT07560618 clinical landscape for Pruritus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
RO-7851624 in Multiple Myeloma: NCT07558915 Clinical Landscape Report 2026
18 September 2026
NCT07558915 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ixekizumab in Plaque psoriasis: ISRCTN91905052 Clinical Landscape Report 2026
18 September 2026
ISRCTN91905052 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Daunorubicin Hydrochloride in Acute Myeloid Leukemia: NCT07561892 Clinical Landscape Report 2026
18 September 2026
NCT07561892 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Busulfan in leukemia acute ambiguous lineage: NCT07565220 Clinical Landscape Report 2026
18 September 2026
NCT07565220 clinical landscape for leukemia acute ambiguous lineage: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Fludarabine Phosphate in Acute Myeloid Leukemia: NCT07563920 Clinical Landscape Report 2026
18 September 2026
NCT07563920 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
[68Ga]Ga-R54 in Advanced Malignant Solid Neoplasm: NCT07577206 Clinical Landscape Report 2026
18 September 2026
NCT07577206 clinical landscape for Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
JNJ-95804306 in Acute Myeloid Leukemia: NCT07572006 Clinical Landscape Report 2026
18 September 2026
NCT07572006 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.